Ashley Krull, Ph.D. Associate Director W.W. Williams Cellular Therapy Laboratory The Ohio State University Columbus, Ohio, USA One week ago, a new manuscript re-introduced the concept of CAR-MSCs and piqued the interest of immunologists and cell biologists afresh. The report,...
A Pioneer in Stem Cell Research, Cancer Treatment, and Advocate for Women in STEM ISCT is deeply saddened by the news of the passing of Dr. Connie Eaves, an international leader in stem cell research, bone marrow transplantation and cancer treatments. As a founding member of ISCT, Dr....
ISCT INVITES YOUR FEEDBACK Cryopreservation in Cell and Gene Therapy Survey The ISCT Cold Chain Management and Logistics Working Group, a sub-committee of the ISCT Process Development & Manufacturing Committee is developing a seven-part survey covering primary container selection,...
Adaeze Ekwe, PhD Junior Associate Editor ISCT ESP Leadership Development Program From the laboratories to the clinics and boardrooms, women have been integral to the progress made in cell and gene therapy. As such for this Women’s History Month and International Women’s Day we...
Jacques Galipeau, MD, MD FRCP(C) President, ISCT Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health A few weeks ago, I gave the opening keynote address at the 2nd edition of the Dubai Stem Cell Conference (DSCC) chaired by...
Are you using prediction algorithms, machine learning (ML), or artificial intelligence (AI) in your work? Are you interested in finding out more about these terms and their applications? As part of a two-part initiative on AI and ML, The ISCT Process Development & Manufacturing Sub...
Wouter Van’t Hof, Contributing Editor Cleveland Cord Blood Center Cleveland OH, USA What’s in Your CGT Product? The shared responsibility of all of us cell and gene therapy developers involved with ISCT and with the ambition of bringing cell-based therapies to...
Janet Macpherson, PhD Cytiva Sydney, Australia Your Telegraft editorial team are dedicating this first issue of 2024 to a reflection of 2023 content and highlights. Please do take the opportunity to catch up on articles that you may have missed during the busy year that...
by Dr. Adaeze Ekwe Junior Associate Editor ISCT ESP Leadership Development Program From the global ISCT Early Stage Professionals (ESPs) committee to regional ESP subcommittees, 2023 was definitely a busy and riveting year for the ESPs. Here is a recap of the Telegraft submissions...
by Jacques Galipeau, MD, MD FRCP(C) President, ISCT Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health There wasn’t a dull moment in 2023 for Cell & Gene Therapy (CGT) aficionados and the ISCT has been riding this bull...